ABO blood type correlates with survival on prostate cancer vaccine therapy

about

Diverse molecular recognition properties of blood group A binding monoclonal antibodies.Key regulators of galectin-glycan interactions.Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy.

P2860

Q36745220-3F35D5A1-E9CB-4469-8069-2C8CF47C9C50 Q38943100-CE7DD968-94A5-4505-802E-AD649B5D08A7 Q41238074-ABAFBC75-45CD-4B18-9F5C-6E62E0D13FBC

P2860

ABO blood type correlates with survival on prostate cancer vaccine therapy

Item

http://www.wikidata.org/entity/Q36544831

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

ABO blood type correlates with survival on prostate cancer vaccine therapy

@ast

ABO blood type correlates with survival on prostate cancer vaccine therapy

@en

type

Item

label

ABO blood type correlates with survival on prostate cancer vaccine therapy

@ast

ABO blood type correlates with survival on prostate cancer vaccine therapy

@en

prefLabel

ABO blood type correlates with survival on prostate cancer vaccine therapy

@ast

ABO blood type correlates with survival on prostate cancer vaccine therapy

@en

P1476

ABO blood type correlates with survival on prostate cancer vaccine therapy

@en

P2093

James L Gulley

http://www.w3.org/2001/XMLSchema#string

James W Hodge

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Gildersleeve

http://www.w3.org/2001/XMLSchema#string

Jeffrey Schlom

http://www.w3.org/2001/XMLSchema#string

Saddam M Muthana

http://www.w3.org/2001/XMLSchema#string

P2860

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome

Construction and use of glycan microarrays.

Glycan microarrays for decoding the glycome.

Humoral response to a viral glycan correlates with survival on PROSTVAC-VF

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

Tulane virus recognizes the A type 3 and B histo-blood group antigens.

Competition between serum IgG, IgM, and IgA anti-glycan antibodies

P304

32244-32256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.4993

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281513300

http://www.w3.org/2001/XMLSchema#string

P698

26338967

http://www.w3.org/2001/XMLSchema#string

P932

4741674

http://www.w3.org/2001/XMLSchema#string

ABO blood type correlates with survival on prostate cancer vaccine therapy

about

P2860

P2860

ABO blood type correlates with survival on prostate cancer vaccine therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932